SK

Shalini Kapoor

Director Director DIN 06751561
DIN 06751561 First appointment Dec 2013 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Shalini Kapoor

Data last updated:

Shalini Kapoor was a Director at Juneva Pharmaceuticals Private Limited (2013–2015) and Director at Trimind Pharmaceuticals Private Limited (from 2015). The companies operate in Trading.

DIN 06751561
Primary Designation Director
Industry Trading
First Appointment 23 Dec 2013
Oldest Company Age 10 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Dec 20132013₹5.6 Lakh (FY 2021)Active
Director10 Nov 20152015Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Trimind Pharmaceuticals Private Limited
Juneva Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shalini Kapoor

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shalini Kapoor

Shalini Kapoor was first appointed on 23 Dec 2013 as Director at Juneva Pharmaceuticals Private Limited. The most recent appointment on record is 10 Nov 2015 at Trimind Pharmaceuticals Private Limited.

Shalini Kapoor held 2 earlier board appointments: Juneva Pharmaceuticals Private Limited (Director, 23 Dec 2013 to 31 Dec 2015); Trimind Pharmaceuticals Private Limited (Director, from 10 Nov 2015).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available